Produkty 1648713-48-7

CAS 1648713-48-7 to numer rejestracyjny substancji 1-(1,1-Dimethylethyl)-3-(phenylmethyl)-2-undecylpropanedioate, 95%, 95%. Oferty producentów: Chemat. Dostępne opakowania: 100mg, 250mg, 1g.

1-(1,1-Dimethylethyl)-3-(phenylmethyl)-2-undecylpropanedioate, 95%, 95%
Chemat
  • opakowanie: 100mg, 250mg, 1g
  • Warianty: 3
od 2128,40
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

3-O-benzyl 1-O-tert-butyl 2-undecylpropanedioate (CAS 1648713-48-7) to związek chemiczny o wzorze sumarycznym C25H40O4 i masie molowej 404.6 g/mol. Nazwa systematyczna IUPAC: 3-O-benzyl 1-O-tert-butyl 2-undecylpropanedioate. InChIKey: LQUDEQKYOJCYPY-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H40O4
Masa molowa404.6 g/mol
Nazwa IUPAC3-O-benzyl 1-O-tert-butyl 2-undecylpropanedioate
InChIKeyLQUDEQKYOJCYPY-UHFFFAOYSA-N
SMILESCCCCCCCCCCCC(C(=O)OCC1=CC=CC=C1)C(=O)OC(C)(C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 1-(1,1-Dimethylethyl)-3-(phenylmethyl)-2-undecylpropanedioate, LQUDEQKYOJCYPY-UHFFFAOYSA-N, 1-Benzyl 3-tert-butyl 2-undecylmalonate, 1-BenZyl 3-(t-butyl) 2-undecylmalonate
Izomery (ten sam wzór sumaryczny)
methyl (4R)-4-[(5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(3R,5R,8S,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(3R,5R,8S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(5R,8R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4S)-4-[(5R,10S,12R,13R,14R,17R)-12-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
[(3R,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-acetyloxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C25H40O4
[(1R,2S,4R,9R,10S,13R,14R)-2,14-dihydroxy-5,5,9-trimethyl-14-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]methyl 3-methylbut-2-enoate C25H40O4
18-oxo-18-phenylmethoxyoctadecanoic acid C25H40O4
methyl (4R)-4-[(5R,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4
methyl (4R)-4-[(5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate C25H40O4